SCHEMBL6694433

SCHEMBL6694433

NC(=O)c1cccc2c1c1c(O)cc(-c3ccccc3)cc1n2Cc1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 11/20 0.46
SRC P12931 1/20 0.42
MEN1 O00255 2/20 0.41
ALDH1A1 P00352 2/20 0.41
KMT2A Q03164 2/20 0.41
POLB P06746 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
PARP1 P09874 1/20 0.41
PLA2G1B P04054 3/20 0.41
KDM4E B2RXH2 1/20 0.40
MAPT P10636 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
SERPINE1 P05121 1/20 0.40
BRD4 O60885 2/20 0.40
PLA2G10 O15496 2/20 0.40
PLA2G5 P39877 1/20 0.40
PLA2G2E Q9NZK7 1/20 0.40
ADRA1D P25100 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6770631 0.95 PLA2G2A (0.46) PLA2G2AMEN1ALDH1A1KMT2APOLB
SCHEMBL6773052 0.94 PLA2G2A (0.50) PLA2G2AALDH1A1L3MBTL1PLA2G1BKDM4E
SCHEMBL6690216 0.93 PLA2G2A (0.43) PLA2G2ASRCMEN1ALDH1A1KMT2A
SCHEMBL6774933 0.92 PLA2G2A (0.42) PLA2G2APLA2G1BPLA2G10PLA2G5PLA2G2E
SCHEMBL6776773 0.92 PLA2G2A (0.42) PLA2G2AALDH1A1PLA2G1BSERPINE1
SCHEMBL6774185 0.91 TP53 (0.47) PLA2G2AMEN1ALDH1A1KMT2ANPSR1
SCHEMBL6775875 0.91 PLA2G2A (0.40) PLA2G2APARP1PLA2G1BPLA2G10ADRA1D
SCHEMBL6770537 0.91 FABP3 (0.41) PLA2G2ASRCPOLBPLA2G1BPLA2G10
SCHEMBL6690152 0.90 KDM4E (0.43) PLA2G2AALDH1A1L3MBTL1PARP1PLA2G1B
SCHEMBL6770280 0.90 PLA2G2A (0.40) PLA2G2AALDH1A1PLA2G1BKDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0952149-A2 Substituted carbazoles, process for their preparation and their use as sPLA2 inhibitiors ELI LILLY AND COMPANY (US) 1999-10-27 EP claimed
EP-0952149-B1 Substituted carbazoles, process for their preparation and their use as sPLA2 inhibitiors LILLY CO ELI (US) 2004-06-09 EP disclosed
US-6713645-B1 INHIBITING SPLA2 MEDIATED RELEASE OF FATTY ACIDS FOR TREATMENT OF CONDITIONS SUCH AS SEPTIC SHOCK ELI LILLY AND COMPANY 2004-03-30 US disclosed
US-6177440-B1 THERAPY FOR SEPSIS SHOCK; PHOSPHOLIPASE INHBITOR ELI LILLY AND COMPANY 2001-01-23 US disclosed
EP-0952149-A2 Substituted carbazoles, process for their preparation and their use as sPLA2 inhibitiors ELI LILLY AND COMPANY (US) 1999-10-27 EP disclosed